Recursion Pharmaceuticals Inc Sustainability Reports

A clinical-stage TechBio company that uses artificial intelligence, machine learning, and automation to map cellular biology and accelerate drug discovery.

Sector: Professional & technical services

Country: United States

Exchange: Nasdaq

FIGI: BBG00PQ4XJ54

6 reports from 2021 to 2024

• Recursion Pharmaceuticals Inc 2024 UK Gender Pay Gap Report
• Recursion Pharmaceuticals Inc 2024 Annual Report
• Recursion Pharmaceuticals Inc 2023 Global Environmental, Social, and Governance Report
• Recursion Pharmaceuticals Inc 2022 Form 10-K
• Recursion Pharmaceuticals Inc 2022 Global Environmental, Social and Governance Report